180 related articles for article (PubMed ID: 24566085)
1. Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2.
Holder BS; Grant CR; Liberal R; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
J Autoimmun; 2014 Sep; 53():26-32. PubMed ID: 24566085
[TBL] [Abstract][Full Text] [Related]
2. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
[TBL] [Abstract][Full Text] [Related]
3. Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α.
Goldberg R; Scotta C; Cooper D; Nissim-Eliraz E; Nir E; Tasker S; Irving PM; Sanderson J; Lavender P; Ibrahim F; Corcoran J; Prevost T; Shpigel NY; Marelli-Berg F; Lombardi G; Lord GM
Gastroenterology; 2019 May; 156(6):1775-1787. PubMed ID: 30710527
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
Huang H; Deng Z
Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis.
Liberal R; Grant CR; Yuksel M; Graham J; Kalbasi A; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2017 Nov; 66(5):1570-1584. PubMed ID: 28597951
[TBL] [Abstract][Full Text] [Related]
6. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.
Grant CR; Holder BS; Liberal R; Heneghan MA; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Clin Exp Immunol; 2017 Jul; 189(1):71-82. PubMed ID: 28257599
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
9. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
[TBL] [Abstract][Full Text] [Related]
10. Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus.
Chu Y; Zhao C; Zhang B; Wang X; Wang Y; An J; Chen J
Lupus; 2019 Oct; 28(12):1397-1406. PubMed ID: 31551029
[TBL] [Abstract][Full Text] [Related]
11. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
12. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
[TBL] [Abstract][Full Text] [Related]
13. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
[TBL] [Abstract][Full Text] [Related]
14. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
[TBL] [Abstract][Full Text] [Related]
15. Migratory properties of ex vivo expanded regulatory T cells: Influence of all-trans retinoic acid and rapamycin.
Beermann JL; Thiesler CT; Dringenberg U; Alter C; Kuhs S; Velaga S; Ukena SN; Franzke A
Transpl Immunol; 2017 Dec; 45():29-34. PubMed ID: 28870639
[TBL] [Abstract][Full Text] [Related]
16. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
Ma Y; Bogdanos DP; Hussain MJ; Underhill J; Bansal S; Longhi MS; Cheeseman P; Mieli-Vergani G; Vergani D
Gastroenterology; 2006 Mar; 130(3):868-82. PubMed ID: 16530525
[TBL] [Abstract][Full Text] [Related]
17. TLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expression.
Chi G; Feng XX; Ru YX; Xiong T; Gao Y; Wang H; Luo ZL; Mo R; Guo F; He YP; Zhang GM; Tian DA; Feng ZH
Mol Immunol; 2018 Jul; 99():171-181. PubMed ID: 29793131
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
Longhi MS; Hussain MJ; Bogdanos DP; Quaglia A; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2007 Aug; 46(2):472-84. PubMed ID: 17559153
[TBL] [Abstract][Full Text] [Related]
20. Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells.
Candia E; Reyes P; Covian C; Rodriguez F; Wainstein N; Morales J; Mosso C; Rosemblatt M; Fierro JA
PLoS One; 2017; 12(7):e0182009. PubMed ID: 28746369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
